Table 1 Characteristics of patients approached for study participation (N = 1,203).
Characteristic | Group | Provided consent (n = 1,084) | Declined to consent (n = 119) | pa |
|---|---|---|---|---|
Sex | Female | 342 (91%) | 34 (9%) | 0.51 |
Male | 742 (90%) | 85 (10%) | ||
Race | White | 878 (93%) | 67 (7%) | <0.001 |
Black/African American | 109 (73%) | 40 (27%) | ||
Asian | 38 (95%) | 2 (5%) | ||
American Indian/Alaska Native | 1 (50%) | 1 (50%) | ||
Other | 46 (88%) | 6 (12%) | ||
Missing | 12 (80%) | 3 (20%) | ||
Ethnicity | Hispanic | 31 (97%) | 1 (3%) | 0.19 |
Not Hispanic | 1005 (90%) | 114 (10%) | ||
Unknown/missing | 48 (92%) | 4 (8%) | ||
Cancer type | Ovarian | 160 (93%) | 12 (7%) | 0.19 |
Prostate | 507 (89%) | 65 (11%) | ||
Pancreas | 417 (91%) | 42 (9%) | ||
Age | Years, mean (SD) | 67.9 (10.1) | 69.5 (10.3) | 0.11 |
Study site | Memorial Sloan Kettering | 406 (97%) | 14 (3%) | <0.001 |
University of Pennsylvania | 678 (87%) | 105 (13%) |
